Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate-to-severe psoriasis: a pooled analysis of two randomized controlled trials
| Image |  |
|---|---|
| Description | scientific article published on 11 September 2019 |
| Author/s |
author: Howard Sofen |
| Publication date | September 11, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |